CHME vs MSFT: Which Stock is Better?
Side-by-side comparison of China Medicine Corporation and Microsoft Corp in 2026
CHME
China Medicine Corporation
$0.02
MSFT
Microsoft Corp
$417.51
Key Metrics Comparison
| Metric | CHME | MSFT | Winner |
|---|---|---|---|
| Market Cap | $0.47M | N/A | CHME |
| P/E Ratio | N/A | 27.43 | MSFT |
| EPS (TTM) | $N/A | $16.79 | MSFT |
| Revenue Growth | -0.1% | 0.2% | MSFT |
| Gross Margin | 33.5% | 68.3% | MSFT |
Analyze CHME
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHME or MSFT a better investment?
Comparing CHME and MSFT: China Medicine Corporation has a market cap of $0.47M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHME and MSFT?
CHME (China Medicine Corporation) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHME or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHME or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.1% for CHME.
Which company is more profitable: CHME or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.3% compared to 33.5% for CHME.
Which is the larger company: CHME or MSFT?
China Medicine Corporation (CHME) is larger with a market cap of $0.47M compared to N/A for MSFT.
Should I buy CHME or MSFT in 2026?
Both CHME and MSFT have investment merit. CHME trades at $0.02 while MSFT trades at $417.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHME and MSFT stock?
Key differences: Market Cap ($0.47M vs N/A), P/E Ratio (N/A vs 27.4x), Revenue Growth (-0.1% vs 0.2%), Gross Margin (33.5% vs 68.3%).